Pyrosequencing as an alternative to single-strand conformation polymorphism analysis for detection of N-ras mutations in human melanoma metastases

Clinical Chemistry

Volumn 48, Issue 12, 2002, Pages 2164-2170

  Sivertsson, Åsa ^a   Platz, Anton ^b   Hansson, Johan ^b   Lundeberg, Joakim ^a  

^a ALBANOVA UNIVERSITY CENTER   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; HISTIDINE; LEUCINE; LYSINE;

ARTICLE; CODON; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EVALUATION; GENE MUTATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MELANOMA; METASTASIS; ONCOGENE N RAS; PYROSEQUENCING; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 18744407256     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.12.2164     Document Type: Article

References (31)

1. Pogue R, West S, Bushby K. Multiplex SSCP and heteroduplex analysis with Southern hybridization for large-scale mutation detection. Genomics 1998;54: 1-4.
2. Nedergaard T, Guldberg P, Ralfkiaer E, Zeuthen J. A one-step DGGE scanning method for detection of mutations in the K-, N-, and H-ras oncogenes: Mutations at codons 12, 13 and 61 are rare in B-cell non-Hodgkin's lymphoma. Int J Cancer 1997;71: 364-9.
3. Moore L, Godfrey T, Eng C, Smith A, Ho R, Waldman FM. Validation of fluorescent SSCP analysis for sensitive detection of p53 mutations. Biotechniques 2000;28: 986-92.
4. Campos B, Diez O, Cortes J, Domenech M, Pericay C, Alonso C, et al. Conditions for single-strand conformation polymorphism (SSCP) analysis of BRCA1 gene using an automated electrophoresis unit. Clin Chem Lab Med 2001;39: 401-4.
5. Fodde R, Losekoot M. Mutation detection by denaturing gradient gel electrophoresis (DGGE). Hum Mutat 1994;3: 83-94.
6. Ridanpaa M, Husgafvel-Pursiainen K. Denaturing gradient gel electrophoresis (DGGE) assay for K-ras and N-ras genes: Detection of K-ras point mutations in human lung tumour DNA. Hum Mol Genet 1993;2: 639-44.
7. Agaton C, Unneberg P, Sievertzon M, Holmberg A, Ehn M, Larsson M, et al. Gene expression analysis by signature pyrosequencing. Gene 2002;289: 31-9.
8. Wasson J, Skolnick G, Love-Gregory L, Permutt MA. Assessing allele frequencies of single nucleotide polymorphisms in DNA pools by pyrosequencing technology. Biotechniques 2002;32: 1144-6,1148,1150,passim.
9. Fakhrai-Rad H, Pourmand N, Ronaghi M. Pyrosequencing: An accurate detection platform for single nucleotide polymorphisms. Hum Mutat 2002;19: 479-85.
10. Andreasson H, Asp A, Alderborn A, Gyllensten U, Allen M. Mitochondrial sequence analysis for forensic identification using pyrosequencing technology. Biotechniques 2002;32: 124-6,128, 130-3.
11. O'Meara D, Wilbe K, Leitner T, Hejdeman B, Albert J, Lundeberg J. Monitoring resistance to human immunodeficiency virus type 1 protease inhibitors by pyrosequencing. J Clin Microbiol 2001;39: 464-73.
12. Garcia CA, Ahmadian A, Gharizadeh B, Lundeberg J, Ronaghi M, Nyren P. Mutation detection by pyrosequencing: Sequencing of exons 5-8 of the p53 tumor suppressor gene. Gene 2000;253: 249-57.
13. Ahmadian A, Gharizadeh B, Gustafsson AC, Sterky F, Nyren P, Uhlen M, et al. Single-nucleotide polymorphism analysis by pyrosequencing. Anal Biochem 2000;280: 103-10.
14. Crespo P, Leon J. Ras proteins in the control of the cell cycle and cell differentiation. Cell Mol Life Sci 2000;57: 1613-36.
15. Barbacid M. Ras genes. Annu Rev Biochem 1987;56: 779-827.
16. Sweet RW, Yokoyama S, Kamata T, Feramisco JR, Rosenberg M, Gross M. The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity. Nature 1984;311: 273-5.
17. Der CJ, Finkel T, Cooper GM. Biological and biochemical properties of human rash genes mutated at codon 61. Cell 1986;44: 167-76.
18. Polakis P, McCormick F. Structural requirements for the interaction of p21ras with GAP, exchange factors, and its biological effector target. J Biol Chem 1993;268: 9157-60.
19. Jiveskog S, Ragnarsson-Olding B, Platz A, Ringborg U. N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin. J Invest Dermatol 1998;111: 757-61.
20. Albino AP, Nanus DM, Mentle IR, Cordon-Cardo C, McNutt NS, Bressler J, et al. Analysis of ras oncogenes in malignant melanoma and precursor lesions: Correlation of point mutations with differentiation phenotype. Oncogene 1989;4: 1363-74.
21. Ball NJ, Yohn JJ, Morelli JG, Norris DA, Golitz LE, Hoeffler JP. Ras mutations in human melanoma: A marker of malignant progression. J Invest Dermatol 1994;102: 285-90.
22. van't Veer LJ, Burgering BM, Versteeg R, Boot AJ, Ruiter DJ, Osanto S, et al. N-ras mutations in human cutaneous melanoma from sun-exposed body sites. Mol Cell Biol 1989;9: 3114-6.
23. Demunter A, Stas M, Degreef H, De Wolf-Peeters C, van den Oord JJ. Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma. J Invest Dermatol 2001;117: 1483-9.
24. Van der Lubbe JL, Rosdorff H J, Bos JL, Van der Eb AJ. Activation of N-ras induced by ultraviolet irradiation in vitro. Oncogene Res 1988;3: 9-20.
25. Tormanen VT, Pfeifer GP. Mapping of UV photoproducts within ras proto-oncogenes in UV-irradiated cells: Correlation with mutations in human skin cancer. Oncogene 1992;7: 1729-36.
26. Price K, Linge C. The presence of melanin in genomic DNA isolated from pigmented cell lines interferes with successful polymerase chain reaction: A solution. Melanoma Res 1999;9: 5-9.
27. Neve B, Froguel P, Corset L, Vaillant E, Vatin V, Boutin P. Rapid SNP allele frequency determination in genomic DNA pools by pyrosequencing. Biotechniques 2002;32: 1138-42.
28. Platz A, Ringborg U, Brahme EM, Lagerlof B. Melanoma metastases from patients with hereditary cutaneous malignant melanoma contain a high frequency of N-ras activating mutations. Melanoma Res 1994;4: 169-77.
29. Odeberg J, Yun Z, Sonnerborg A, Uhlen M, Lundeberg J. Dynamic analysis of heterogeneous hepatitis C virus populations by direct solid-phase sequencing. J Clin Microbiol 1995;33: 1870-4.
30. Leitner T, Halapi E, Scarlatti G, Rossi P, Albert J, Fenyo EM, et al. Analysis of heterogeneous viral populations by direct DNA sequencing. Biotechniques 1993;15: 120-7.
31. Demunter A, Ahmadian MR, Libbrecht L, Stas M, Baens M, Scheffzek K, et al. A novel N-ras mutation in malignant melanoma is associated with excellent prognosis. Cancer Res 2001;61: 4916-22.